Edition:
United Kingdom

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

56.46USD
5:55pm GMT
Change (% chg)

$-3.75 (-6.23%)
Prev Close
$60.21
Open
$61.22
Day's High
$61.22
Day's Low
$54.55
Volume
78,907
Avg. Vol
117,963
52-wk High
$108.62
52-wk Low
$54.55

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 1.10 -1.656
Jun '18 41.44 -0.617
Mar '18 0.95 -1.294
FY 2017 Dec '17 1.63 -1.225
Sep '17 8.07 -0.964
Jun '17 5.89 -0.862
Mar '17 5.84 -0.843
FY 2016 Dec '16 7.69 -0.747
Sep '16 6.16 -0.618
Jun '16 7.07 -0.695
Mar '16 6.86 -0.572
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 1.73 3.40 1.00 3.61
Quarter Ending Mar-19 6 2.00 5.00 1.00 --
Year Ending Dec-18 9 45.25 46.90 44.50 13.88
Year Ending Dec-19 9 6.53 20.00 0.00 14.90
Earnings (per share)
Quarter Ending Dec-18 9 -1.71 -1.30 -1.90 -1.22
Quarter Ending Mar-19 7 -1.79 -1.41 -2.16 --
Year Ending Dec-18 9 -5.28 -4.86 -5.48 -4.87
Year Ending Dec-19 9 -7.61 -5.98 -9.35 -5.31
LT Growth Rate (%) 1 34.00 34.00 34.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.49 33.64
P/E High - Last 5 Yrs. -- 308.80 45.61
P/E Low - Last 5 Yrs. -- 85.15 23.70
Beta -- 0.93 0.88
Price to Sales (TTM) 101.33 121.71 5.95
Price to Book (MRQ) 6.92 14.77 4.89
Price to Tangible Book (MRQ) 6.93 13.90 6.50
Price to Cash Flow (TTM) -- 66.81 22.90
% Owned Institutions -- 13.77 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.51
Dividend Yield - 5 Year Avg -- 0.31 1.52
Dividend 5 Year Growth Rate -- 2.84 5.41
Payout Ratio(TTM) -- 25.52 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -16.63 387.07 8.08
Sales (TTM) vs TTM 1 Yr. Ago 16.37 97.70 5.80
Sales - 5 Yr. Growth Rate -- 29.11 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.91 27.93 23.27
EPS (TTM) vs TTM 1 Yr. Ago -32.61 -- --
EPS - 5 Yr. Growth Rate -- 33.15 10.88
Capital Spending - 5 Yr. Growth Rate -- 36.76 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 2.27
Current Ratio (MRQ) 13.07 5.29 3.07
LT Debt to Equity (MRQ) 0.18 36.70 13.15
Total Debt to Equity (MRQ) 0.71 38.52 17.74
Interest Coverage (TTM) -103.52 -90.95 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.86
Gross Margin - 5 Yr. Avg. -- 48.29 52.38
EBITD Margin (TTM) -387.82 -- --
EBITD - 5 Yr. Avg -- -554.66 10.90
Operating Margin (TTM) -394.04 -797.48 3.24
Operating Margin - 5 Yr. Avg. -- -575.64 6.22
Pre-Tax Margin (TTM) -388.91 -760.60 4.31
Pre-Tax Margin - 5 Yr. Avg. -- -581.03 6.66
Net Profit Margin (TTM) -388.91 -761.46 0.58
Net Profit Margin - 5 Yr. Avg. -- -583.67 2.90
Effective Tax Rate (TTM) -- 25.03 23.26
Effective Tax Rate - 5 Yr. Avg. -- 19.86 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 241,330 22,792,354 803,310,882
Net Income/Employee (TTM) -938,547 1,402,733 94,478,474
Receivable Turnover (TTM) 7.96 19.90 5.78
Inventory Turnover (TTM) -- 2.68 3.71
Asset Turnover (TTM) 0.08 0.42 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.52 -1.66 10.86
Return on Assets - 5 Yr. Avg. -- 2.77 11.96
Return on Investment (TTM) -34.88 -0.29 14.22
Return on Investment - 5 Yr. Avg. -- 1.51 15.54
Return on Equity (TTM) -40.89 0.40 15.99
Return on Equity - 5 Yr. Avg. -- 1.96 16.82
  1 Year 3 Year 5 Year
Sales % 143.61 -- --
EPS (TTM) % 14.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Blueprint Medicines Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 26.74 22.37 99 58
13 Week 24.13 18.08 99 61
26 Week 48.03 36.78 99 74
52 Week 147.42 109.71 99 45
YTD 136.22 107.45 99 55
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 261
Total Shares Held: 45,324,756
3 Mo. Net Change: 44,969
# New Positions: 14
# Closed Positions: 12
# Increased Positions: 55
# Reduced Positions: 43
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.